EDAP TMS S.A. (FRA:EDA)

Market Cap	154.21M +162.1%
Revenue (ttm)	64.24M +9.2%
Net Income	-26.79M
EPS	-0.71
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	3.920
Previous Close	4.000
Day's Range	3.920 - 3.920
52-Week Range	1.010 - 4.060
Beta	n/a
Analysts	Buy
Price Target	5.37 (+36.99%)
Earnings Date	May 7, 2026

About EDAP TMS

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Fo...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 289
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EDA

Financial Performance

In 2025, EDAP TMS's revenue was $70.53 million, an increase of 1.63% compared to the previous year's $69.40 million. Losses were -$29.25 million, 42.1% more than in 2024.

Financial numbers in USD

Analyst Summary

According to 2 analysts, the average rating for EDA stock is "Buy." The 12-month stock price target is €5.37, which is an increase of 36.99% from the latest price.

Price Target

€5.37

(36.99% upside)

Analyst Consensus: Buy